We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£111.72
Springer - Safety of Biologics Therapy Medical Reference
Price data last checked 40 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£112 today · previous high £112 · all-time low £110
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 51 days • 51 data points (No recent data available)
Price Distribution
Price distribution over 51 days • 2 price levels
Price Analysis
Most common price: £112 (29 days, 56.9%)
Price range: £110 - £112
Price levels: 2 different prices over 51 days
Description
Key Features
Comprehensive review of approved biologic therapies including monoclonal antibodies, cytokines, and fusion proteins.
Detailed examination of mechanisms of action and clinical indications for various therapeutic agents.
In-depth analysis of immunogenicity and adverse effects to support patient safety.
Thirteen chapters covering diverse classes such as hormones, enzymes, and vaccines.
Updated information addressing the growing market share of recombinant proteins in global medicine.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 3319304704
- Domain
- Amazon UK
- Release Date
- 18 May 2016
- Listed Since
- 23 January 2016
Barcode
No barcode data available
Similar Products You Might Like
Safety of Biologics Therapy: Monoclonal Antibodies, Cytokines, Fusion Proteins, Hormones, Enzymes, Coagulation Proteins, Vaccines, Botulinum Toxins
Springer
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
CRC Press
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
CRC Press
Biopharmaceuticals: Biochemistry and Biotechnology
Wiley-Blackwell
Biologics in General Medicine
Springer
Fundamentals of Medical Biotechnology (Recent Trends in Biotechnology)
Biopharmaceuticals: Challenges and Opportunities
CRC Press
Springer Novel Frontiers in Production of Biomedical Compounds
Springer
Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
Wiley
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
Elsevier
Biologics and Biosimilars: Drug Discovery and Clinical Applications
CRC Press
Biotechnology in India II: 85 (Advances in Biochemical Engineering/Biotechnology)
Springer
Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins
Wiley
Emerging Protein Biotherapeutics
CRC Press
The Biotech Business Handbook: How to Organize and Operate a Biotechnology Business, Including the Most Promising Applications for the 1990s
Humana
In vitro Environmental Toxicology - Concepts, Application and Assessment: 157 (Advances in Biochemical Engineering/Biotechnology, 157)
Springer
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
Academic Press
Novel Therapeutics from Modern Biotechnology: From Laboratory to Human Testing: 137 (Handbook of Experimental Pharmacology, 137)
Springer
Developability of Biotherapeutics: Computational Approaches
CRC Press
Biotechnology in India I: 84 (Advances in Biochemical Engineering/Biotechnology, 84)
Springer
Wiley Biotech Industry - Global Economic and Financing Overview
Wiley
Biotechnology in India I: 84 (Advances in Biochemical Engineering/Biotechnology)
Springer
Comprehensive Biotechnology, 2nd edition
Pergamon
Biotechnology Annual Review: 9: Volume 9
Elsevier